Institute of Experimental Pharmacology, Slovak Academy of Sciences Dúbravská 2, 842 16, Bratislava, Czecho-Slovakia.
Platelets. 1992;3(1):29-33. doi: 10.3109/09537109209013165.
The effects of the beta-adrenoceptor blockers (BAB) alprenolol, atenolol, metipranolol, oxprenolol, practolol and propranolol on platelet aggregation stimulated by ADP, thrombin and collagen were investigated. The BAB were divided into three groups according to their liposolubility and antiaggregatory activity. The first group consists of the highly active drugs alprenolol and propranolol; metipranolol and oxprenolol are in the second group; the least active atenolol and practolol are in the third group. Collagen induced platelet aggregation was inhibited by BAB to the highest extent, followed by inhibition of thrombin stimulated aggregation. ADP-induced aggregation was inhibited to the lowest extent. Consistent with the rank order of their partition coefficients, BAB inhibited aggregation with the following order of potency: propranolol > alprenolol > metipranolol > oxprenolol > practolol > atenolol. A positive correlation was found between inhibition of thrombin and collagen stimulated platelet aggregation and the partition coefficients of the individual drugs. A significant time-dependent inhibition of platelet aggregation developed within 30 s of exposure of blood platelets to BAB.
研究了β-肾上腺素受体阻滞剂(BAB)阿普洛尔、阿替洛尔、美普洛尔、氧烯洛尔、普萘洛尔和心得安对 ADP、凝血酶和胶原刺激的血小板聚集的影响。根据脂溶性和抗聚集活性,BAB 分为三组。第一组由高活性药物阿普洛尔和心得安组成;美托洛尔和氧烯洛尔属于第二组;阿替洛尔和普萘洛尔是最不活跃的第三组。BAB 对胶原诱导的血小板聚集的抑制作用最强,其次是对凝血酶刺激的聚集的抑制作用。ADP 诱导的聚集受 BAB 的抑制作用最小。与它们的分配系数的等级顺序一致,BAB 以以下效力顺序抑制聚集:心得安>阿普洛尔>美托洛尔>氧烯洛尔>普萘洛尔>阿替洛尔。发现凝血酶和胶原刺激的血小板聚集抑制与各药物的分配系数之间存在正相关关系。在血液血小板暴露于 BAB 30 秒内,血小板聚集的时间依赖性抑制明显发展。